Cargando…
The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A propensity score matching analysis
OBJECTIVES: To evaluate the detection rate of clinically significant prostate cancer (csPCa) in Magnetic resonance imaging and ultrasonography (MRI/US) fusion biopsy in patients with biopsy-naïve men for varying prostate-specific antigen (PSA) levels. Since MRI can efficiently detect csPCa compared...
Autores principales: | Byun, Hye J., Shin, Teak J., Jung, Wonho, Ha, Ji Y., Kim, Byung H., Kim, Young H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042765/ https://www.ncbi.nlm.nih.gov/pubmed/35510102 http://dx.doi.org/10.1016/j.prnil.2021.10.002 |
Ejemplares similares
-
Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients
por: Wang, Luke L., et al.
Publicado: (2021) -
Effectiveness of Bi-Parametric MR/US Fusion Biopsy for Detecting Clinically Significant Prostate Cancer in Prostate Biopsy Naïve Men
por: Kim, Young Joo, et al.
Publicado: (2019) -
Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy
por: Uriburu-Pizarro, Facundo, et al.
Publicado: (2017) -
Early Experience with MRI-ultrasound Fusion-guided Prostate Biopsy in Japanese Men with Elevated PSA Levels
por: Tamada, Tsutomu, et al.
Publicado: (2019) -
Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
por: Song, Byeongdo, et al.
Publicado: (2022)